Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes

A major challenge faced by the modern medicine is to develop the safer and more effective therapies to treat human diseases. Most of the drugs that are used were lacking their underlying molecular mechanisms. It is important to understand the biological targets and modes of action to design improved second-generation compounds.